Search

everythinglearnresearchcommunity

for

Search:↓

A trial found that using finasteride, a hair growth drug, can be effectively measured by comparing before and after photos.

Patients with Alopecia Areata often have higher anxiety and depression.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

Patients and doctors find current hair loss treatments unsatisfying and believe involving patients in decisions improves results.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

The hair fiber filler product increased satisfaction and improved quality of life for people with thinning hair.

Endoscopic brow-lift is effective and well-tolerated, with high patient satisfaction and improved appearance.

Hair regrowth in Alopecia Areata patients leads to increased satisfaction and reduced stress.

Middle-aged patients, those in the Northeast, with comprehensive insurance, extensive hair loss, or additional health issues, and young or older females face higher alopecia areata medical costs.

Empathy and better training for doctors are needed to improve alopecia care.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Patients with psoriasis and cutaneous-oral lichen planus have higher blood homocysteine levels than healthy people.

Patients with the same vitamin D receptor mutation showed different symptoms due to other factors.

Alopecia areata negatively impacts quality of life and work, even with moderate hair loss.

High-quality validation studies are needed to improve alopecia areata patient-reported outcome measures.

The HAIR-Q is a reliable tool for assessing patient satisfaction with hair loss treatments.

Ritlecitinib improves hair regrowth satisfaction in alopecia areata patients.

Patients and clinicians generally agree on eyebrow and eyelash hair loss improvements in severe alopecia areata.

The study created a 27-item measure to assess the impact of skin diseases.

Patients with alopecia areata use social media for information but trust their doctors more.

Patients with alopecia areata may have lower vitamin D levels than healthy people.

Patients with advanced breast cancer and high hormone receptor levels who had surgery for ovarian/pelvic metastases lived longer, especially if they had high estrogen receptor levels.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

Disease-specific tools better assess alopecia areata's impact on quality of life.

Patients with alopecia areata prefer effective, safe, and convenient treatments, especially topical ones.

Aesthetic medicine needs clear ethical guidelines to ensure patient well-being and safety.

Patients generally feel positive about alopecia areata treatments, but emotions vary by treatment type.

Most patients were happy with the hair fiber filler and had no serious side effects.

The document concludes that improving patient safety and quality is increasingly important in dermatology.

Doctors must fully inform patients about hair transplant surgery to help them decide and reduce legal issues.